Kilitch Drugs

{
  "main_header": {
    "sid": 189669,
    "name": "Kilitch Drugs",
    "stock_name": "Kilitch Drugs",
    "full_name": "Kilitch Drugs (India) Ltd",
    "name_url": "stocks-analysis/kilitch-drugs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "310.60",
    "chg": -17.15,
    "chgp": "-5.23%",
    "dir": -1,
    "prev_price": "327.75",
    "mcapval": "566.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524500,
    "symbol": "KILITCH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE729D01010",
    "curr_date": "Mar 13",
    "curr_time": "",
    "bse_nse_vol": "16.85 k",
    "exc_status": "Active",
    "traded_date": "Mar 13, 2026",
    "traded_date_str": "2026 03 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/kilitch-drugs-189669-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Kilitch Drugs (India) Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-strong-sell-3888312",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KilitchDrugsInd_mojoScore_3888312.png",
        "date": "2026-03-13 10:10:43",
        "description": "Kilitch Drugs (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 13 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Why is Kilitch Drugs (India) Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-kilitch-drugs-india-ltd-fallingrising-3872260",
        "imagepath": "",
        "date": "2026-03-05 01:08:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>The stock has been on a downward trajectory for the past three consecutive days, cumulatively losing 4.14% in value during this period. On the day in question, Kilitch Drugs touched an intraday low of ₹310.55, marking a 2.4% drop from its previous close. This decline is particularly significant given that the stock underperformed its sector by 0.62% on the same day, signalling relative weakness within its industry group.</p>\n<p>Comparing Kilitch Drugs’ performance against the benchmark Sensex reveals a more nuanced picture. Over the past week, the stock fell by 2.55%, which, while negative, was less severe than the Sensex’s 3.84% decline. However, over the one-month horizon, Kilitch Drugs’ losses of 11.35% substantially outpaced the Se..."
      },
      {
        "title": "Kilitch Drugs (India) Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-strong-sell-3863990",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/KilitchDrugsInd_mojoScore_3863990.png",
        "date": "2026-03-02 10:10:49",
        "description": "Kilitch Drugs (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 02 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Kilitch Drugs Falls 4.43%: 3 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-falls-443-3-key-factors-driving-the-weekly-decline-3863222",
        "imagepath": "",
        "date": "2026-03-01 13:01:01",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>16 Feb:</strong> Stock opens at Rs.322.40, down 2.18% amid broader market gains</p>\n                    <p><strong>18 Feb:</strong> Price rallies to Rs.330.00 (+1.59%) on mild technical momentum shift</p>\n                    <p><strong>19 Feb:</strong> Kilitch Drugs upgraded to Sell rating by MarketsMOJO</p>\n                    <p><strong>20 Feb:</strong> Stock closes week at Rs.315.00, down 1.58% amid bearish technical signals</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.329.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-l..."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-faces-bearish-momentum-amid-technical-downturn-3847637",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KilitchDrugsInd_technicaldot_3847637.png",
        "date": "2026-02-20 08:00:44",
        "description": "Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a series of technical indicators signalling increased selling pressure, with the stock price retreating 3.02% on 20 Feb 2026 to ₹320.05, down from the previous close of ₹330.00. Investors and analysts are closely monitoring these developments amid a challenging market backdrop for the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kilitch Drugs Upgraded to Sell: Comprehensive Analysis of Quality, Valuation, Financial Trend, and Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-upgraded-to-sell-comprehensive-analysis-of-quality-valuation-financial-trend-and-technicals-3846341",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KilitchDrugsInd_mojoScore_3846341.png",
        "date": "2026-02-19 08:02:54",
        "description": "Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 Feb 2026, reflecting a nuanced shift in its valuation and technical outlook despite ongoing financial challenges. The pharmaceutical company’s recent quarterly results and market performance have prompted a reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals."
      },
      {
        "title": "Kilitch Drugs (India) Ltd Shows Mixed Technical Signals Amid Mild Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-india-ltd-shows-mixed-technical-signals-amid-mild-momentum-shift-3846204",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KilitchDrugsInd_technicaldot_3846204.png",
        "date": "2026-02-19 08:00:28",
        "description": "Kilitch Drugs (India) Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a strongly bearish stance to a more mildly bearish or mixed outlook. Despite a modest day gain of 1.59%, the stock’s technical parameters reveal a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Kilitch Drugs Declines 7.40%: Mixed Technicals and Financial Pressures Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/kilitch-drugs-declines-740-mixed-technicals-and-financial-pressures-shape-the-week-3841111",
        "imagepath": "",
        "date": "2026-02-15 14:01:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>9 Feb:</strong> Stock opens strong at ₹366.05 (+2.84%) amid mixed technical signals</p>\n                    <p><strong>10 Feb:</strong> Sideways momentum noted; stock closes at ₹369.05 (+0.82%)</p>\n                    <p><strong>12 Feb:</strong> Quarterly results reveal declining profitability; stock plunges 9.53% to ₹331.75</p>\n                    <p><strong>13 Feb:</strong> Technical downturn intensifies; stock falls 10.01% to ₹329.60</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.355.95</div></div>\n                    <div class=\"stat-item\"><div clas..."
      },
      {
        "title": "Kilitch Drugs (India) Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/kilitch-drugs-india-ltd-is-rated-strong-sell-3840844",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/KilitchDrugsInd_mojoScore_3840844.png",
        "date": "2026-02-15 10:10:32",
        "description": "Kilitch Drugs (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 February 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 293,
    "sid": "189669",
    "stock_news_url": "https://www.marketsmojo.com/news/kilitch-drugs-india-189669"
  },
  "announcements": [
    {
      "details": "Kilitch Drugs (India) Limited has informed the Exchange regarding a press release dated December 09, 2019, titled \"Kilitch Drugs to set-up second green field Project in Ethiopia at an investment of USD 5 mn\".",
      "source": "NSE",
      "caption": "Kilitch Drugs (India) Limited - Press Release",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Kilitch Drugs (India) Limited has informed the Exchange regarding Board meeting held on November 13, 2019.",
      "source": "NSE",
      "caption": "Kilitch Drugs (India) Limited - Outcome of Board Meeting",
      "datetime": "14-Nov-2019"
    },
    {
      "details": " <table><tr><td>Kilitch Drugs (India) Limited has informed the Exchange regarding Board meeting held on September 19, 2019. </td></tr></table>",
      "source": "NSE",
      "caption": "Outcome of Board Meeting",
      "datetime": "19-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has declared <strong>5%</strong> dividend, ex-date: 20 Sep 19",
          "dt": "2019-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Kilitch Drugs (India) Ltd has announced <strong>2:23</strong> rights issue, ex-date: 15 Jul 25",
          "dt": "2025-07-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Kilitch Drugs (India) Ltd is Rated Strong Sell

2026-03-13 10:10:43

Kilitch Drugs (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 13 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Why is Kilitch Drugs (India) Ltd falling/rising?

2026-03-05 01:08:36

Recent Price Movement and Market Context

The stock has been on a downward trajectory for the past three consecutive days, cumulatively losing 4.14% in value during this period. On the day in question, Kilitch Drugs touched an intraday low of ₹310.55, marking a 2.4% drop from its previous close. This decline is particularly significant given that the stock underperformed its sector by 0.62% on the same day, signalling relative weakness within its industry group.

Comparing Kilitch Drugs’ performance against the benchmark Sensex reveals a more nuanced picture. Over the past week, the stock fell by 2.55%, which, while negative, was less severe than the Sensex’s 3.84% decline. However, over the one-month horizon, Kilitch Drugs’ losses of 11.35% substantially outpaced the Se...

Read full news article

Kilitch Drugs (India) Ltd is Rated Strong Sell

2026-03-02 10:10:49

Kilitch Drugs (India) Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 02 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Kilitch Drugs Falls 4.43%: 3 Key Factors Driving the Weekly Decline

2026-03-01 13:01:01

Key Events This Week

16 Feb: Stock opens at Rs.322.40, down 2.18% amid broader market gains

18 Feb: Price rallies to Rs.330.00 (+1.59%) on mild technical momentum shift

19 Feb: Kilitch Drugs upgraded to Sell rating by MarketsMOJO

20 Feb: Stock closes week at Rs.315.00, down 1.58% amid bearish technical signals

Week Open

Rs.329.60

Read full news article

Kilitch Drugs (India) Ltd Faces Bearish Momentum Amid Technical Downturn

2026-02-20 08:00:44

Kilitch Drugs (India) Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a series of technical indicators signalling increased selling pressure, with the stock price retreating 3.02% on 20 Feb 2026 to ₹320.05, down from the previous close of ₹330.00. Investors and analysts are closely monitoring these developments amid a challenging market backdrop for the Pharmaceuticals & Biotechnology sector.

Read full news article

Kilitch Drugs Upgraded to Sell: Comprehensive Analysis of Quality, Valuation, Financial Trend, and Technicals

2026-02-19 08:02:54

Kilitch Drugs (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 18 Feb 2026, reflecting a nuanced shift in its valuation and technical outlook despite ongoing financial challenges. The pharmaceutical company’s recent quarterly results and market performance have prompted a reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Read full news article

Kilitch Drugs (India) Ltd Shows Mixed Technical Signals Amid Mild Momentum Shift

2026-02-19 08:00:28

Kilitch Drugs (India) Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a strongly bearish stance to a more mildly bearish or mixed outlook. Despite a modest day gain of 1.59%, the stock’s technical parameters reveal a complex interplay of bullish and bearish signals, reflecting cautious investor sentiment in the Pharmaceuticals & Biotechnology sector.

Read full news article

Kilitch Drugs Declines 7.40%: Mixed Technicals and Financial Pressures Shape the Week

2026-02-15 14:01:07

Key Events This Week

9 Feb: Stock opens strong at ₹366.05 (+2.84%) amid mixed technical signals

10 Feb: Sideways momentum noted; stock closes at ₹369.05 (+0.82%)

12 Feb: Quarterly results reveal declining profitability; stock plunges 9.53% to ₹331.75

13 Feb: Technical downturn intensifies; stock falls 10.01% to ₹329.60

Week Open

Rs.355.95

Read full news article

Kilitch Drugs (India) Ltd is Rated Strong Sell

2026-02-15 10:10:32

Kilitch Drugs (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 February 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News